Status:
COMPLETED
Anxiety Associated With the Use of the Electrocardiogram Function in Smart Watches
Lead Sponsor:
ITMO University
Conditions:
Mental Health Wellness 1
Anxiety Disorders
Eligibility:
All Genders
22-100 years
Phase:
NA
Brief Summary
The integration of electrocardiography (ECG) functionality into smartwatches is primarily intended to screen for atrial fibrillation, a frequent cause of ischemic stroke, among people aged 50 years an...
Eligibility Criteria
Inclusion
- Status of a student or employee of ITMO University;
- Availability of a smart watch with ECG function (Apple Watch Series 4 and newer, Galaxy Watch Active2, Samsung Galaxy Watch Series 3 and newer or similar with ECG function);
- Availability of a Galaxy smartphone running Android 7.0 or newer or availability of an iPhone 8 and newer smartphone with the latest version of iOS.
- Signed Informed consent and Consent for Data Processing of Personal Data;
- Absence of previously diagnosed clinically significant cardiovascular pathology.
Exclusion
- Participants under the age of 22 cannot be included in the study;
- Participants in the acute phase of any disease or in the exacerbation of chronic diseases are excluded from the study.
Key Trial Info
Start Date :
November 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 4 2024
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT06131463
Start Date
November 13 2023
End Date
March 4 2024
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ITMO University
Saint Petersburg, Russia, 197101